Murine-Equivalent Protocol (3 mL = ~1.67 mg/mL)
| Phase | Example amount (mcg) | Per-Measurement Dose (mcg) | Units per Measurement (mL) |
|---|---|---|---|
| Weeks 1–2 | 1250 mcg | 625 mcg | 37.5 units (0.375 mL) |
| Weeks 3–8 | 2500 mcg | 1250 mcg | 75 units (0.75 mL) |
Route & Frequency: Published murine studies used intraperitoneal preparation twice daily (25–50 mg/kg)[1][2][3]. Daily mcg values above are expressed for a 25 g mouse. No reputable sources support once-daily use for this compound.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Measure slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Critical: This guide reflects preclinical murine research only. This information is for educational and research purposes exclusively —not for human consumption. No human safety or efficacy data exist for SLU-PP-332.
How This Works
SLU-PP-332 is a synthetic small-molecule pan-agonist of the estrogen-related receptors (ERRα, ERRβ, and ERRγ), with strongest activity at ERRα[1][11]. In murine studies, acute preparation activated an aerobic-exercise transcriptional program, increased mitochondrial respiration and fatty-acid oxidation in skeletal muscle, and improved endurance capacity and cardiometabolic phenotypes[3]. The compound acts as an “exercise mimetic” by engaging metabolic pathways typically activated during physical training, without requiring the mechanical stress of actual exercise. However, all evidence to date is preclinical—no human trials have been conducted.
Preclinical Observations
Findings from murine studies only.
- Metabolic effects: Enhanced mitochondrial function, increased fatty-acid oxidation, improved glucose tolerance in diet-induced obese mice[2].
- Cardiac benefits: Ameliorated heart failure through enhanced cardiac fatty-acid metabolism and mitochondrial function in preclinical models[3].
- Endurance enhancement: Increased treadmill running capacity and muscle oxidative capacity in mice[1].
- Renal effects: Reversed mitochondrial dysfunction and inflammation in aging kidney models[4].
- Human safety unknown: No data on human tolerability, pharmacokinetics, or adverse effects exist.
Research Considerations
Contextual factors for preclinical research.
- SLU-PP-332 was studied alongside exercise training in some murine models, suggesting potential synergistic effects.
- Diet composition (standard chow vs. high-fat diet) influenced metabolic outcomes in published studies.
- Environmental controls (temperature, housing conditions) should be standardized in research protocols.
- Compound stability and handling procedures are critical for reproducible results.